Disease Overview：Unstable Angina（UA）
Unstable angina is an acute coronary syndrome characterized by new-onset, worsening, or rest-induced chest pain due to transient myocardial ischemia—without persistent ST-segment elevation or detectable cardiac biomarker elevation (e.g., troponin). Unlike stable angina, it reflects dynamic coronary obstruction, often from plaque rupture, thrombus formation, or vasospasm, and carries significant short-term risk of myocardial infarction or sudden cardiac death. Diagnosis relies on clinical assessment, electrocardiography (ECG), serial cardiac biomarkers, and confirmatory coronary angiography. Management prioritizes rapid risk stratification, anti-ischemic and antithrombotic pharmacotherapy (e.g., dual antiplatelet agents, beta-blockers, statins), and timely revascularization—either percutaneous coronary intervention (PCI) with drug-eluting stents or coronary artery bypass grafting (CABG)—based on lesion complexity and patient profile.
China offers distinct advantages for unstable angina treatment: its tier-3 cardiovascular centers house internationally trained interventional cardiologists with extensive experience in complex PCI and hybrid revascularization; state-of-the-art facilities feature intravascular ultrasound (IVUS), optical coherence tomography (OCT), and robotic-assisted PCI platforms; outcomes align with global benchmarks—studies from Fuwai Hospital and Shanghai Ruijin report 30-day MACE rates under 3.5% in high-risk cohorts. Crucially, comprehensive care—including diagnostics, stenting, and post-procedural rehabilitation—is delivered at approximately 40–60% lower cost than in the US or Western Europe, without compromising evidence-based protocols.
As a dedicated medical tourism agency, we facilitate seamless access to these resources: verifying hospital accreditation, coordinating appointments with top-tier cardiologists, providing itemized, transparent pricing, and offering end-to-end support—from visa assistance and medical translation to accommodation and follow-up coordination—ensuring international patients receive timely, high-quality, and financially sustainable care.
Unstable Angina: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Unstable Angina (Cardiology Department)
Non-Surgical / Conservative Management
*Target Criteria:* Low-to-intermediate GRACE/CRUSADE risk, no dynamic ECG changes or troponin elevation, stable hemodynamics, no contraindications to dual antiplatelet therapy (DAPT).
- •Initial Stabilization (24–72 hrs)
- IV heparin (enoxaparin or unfractionated): $22–$38 - High-intensity statin (e.g., atorvastatin 80 mg): $12–$16/month
- •Outpatient Maintenance (Monthly)
- Beta-blocker (metoprolol succinate): $8–$14 - ACEi/ARB (perindopril or valsartan): $10–$18
- •Essential Diagnostic Fees (One-time)
- ECG stress test (treadmill): $35–$48 - Lipid panel + hs-CRP + renal function: $28
Surgical / Procedural Intervention
*Eligibility Criteria:* Persistent ischemia despite optimal medical therapy, dynamic ST depression ≥1 mm, positive stress imaging, or angiographic evidence of ≥70% stenosis in ≥1 major epicardial vessel.
- •Coronary Angiography (Diagnostic)
- Procedure (femoral/radial access, contrast, fluoroscopy): $1,280–$1,650
- •Percutaneous Coronary Intervention (PCI)
- Glycoprotein IIb/IIIa inhibitor (if high thrombus burden): $185–$260
- •CABG (Reserved for left main disease, multivessel CAD with diabetes/LV dysfunction)
- Surgery (on-pump, 3-vessel): $8,400–$11,200
Special/Complex Condition Management
- •Unstable Angina with Acute Heart Failure (Killip II–III)
- ICU monitoring (per day): $210–$295
- •Renal Impairment (eGFR <30 mL/min)
- Hemodialysis session (pre/post angiography): $145/session
Quick Selection Guide
- •Age <65, low comorbidity burden, moderate severity: Start with conservative management ($120–$210 initial month) → escalate to PCI if recurrent events (+$2,950+).
- •Age ≥75, diabetes, multivessel disease: Direct referral for angiography (+$1,280) → PCI preferred over CABG unless LAD+LM involvement (+$2,950–$5,100).
- •Budget-constrained (<$1,000 total): Strict medical therapy only — aspirin, generic metoprolol, rosuvastatin ($75–$110/month); avoid invasive procedures without clear ischemic evidence.
- •High-risk (troponin+, ST depression): Immediate angiography within 24 hrs (+$1,280) → PCI within 48 hrs (+$2,950+) — *cost-effective vs. prolonged hospitalization*.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Unstable Angina Medical Vacation Packages
Curated transparent all-inclusive packages combining Unstable Angina treatment with China top medical destinations:
